Pdt Partners, LLC Merck & Co., Inc. Transaction History

Pdt Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $1.14 Million - $1.29 Million	13,600 New	13,600 $1.24 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $1.18 Million - $1.32 Million	-16,037 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.16 Million - $1.45 Million	16,037 New	16,037 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $379,674 - $419,958	-5,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $4.5 Million - $5.3 Million	-65,400 Reduced 92.37%	5,400 $416,000
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $2.29 Million - $2.54 Million	-31,839 Reduced 31.02%	70,800 $5.79 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $2,268 - $2,571	31 Added 0.03%	102,639 $8.51 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $225,484 - $256,576	3,202 Added 3.22%	102,608 $7.94 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $117,596 - $162,993	1,856 Added 1.9%	99,406 $7.65 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $7.57 Million - $8.54 Million	97,550 New	97,550 $8.87 Million

3,819

1.87B

15.6M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.